Navigation Links
Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
Date:5/6/2008

SUNNYVALE, Calif., May 6 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) announced today that the Company will present at the following investor conferences:

-- The Robert W. Baird Growth Stock Conference on May 13 at 12:15 p.m. EDT

at The Four Seasons Hotel in Chicago

-- The Bank of America Healthcare Conference on May 14 at 3:40 p.m. EDT at

The Four Seasons Hotel in Las Vegas

John Bishop, Chief Executive Officer, and Andrew Miller, Senior Vice President, Chief Financial Officer, will provide a corporate overview at each conference.

Live webcasts, along with accompanying presentation slides, may be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentations will be available for 90 days following the live events.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU101LOGO)


'/>"/>
SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
2. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
3. Cepheid Reports Fourth Quarter and Full Year 2007 Results
4. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
5. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
6. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
7. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
8. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
9. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
10. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
11. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2020)... ... ... Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving ... of extended antigen in a gel testing format used for blood phenotyping for patients ... Max in the United States and Canada. The clearances allow testing for more than ...
(Date:3/4/2020)... ... March 04, 2020 , ... This month, Cognosante will make its ... company will showcase both expanded and emerging offerings that align with the HIMSS annual ... designed to be comprehensive, timely, and engaging. From Interoperability and HIE ...
(Date:2/28/2020)... ... 26, 2020 , ... Designed primarily for laboratory and industrial ... controller, thus simplifying setup, streamlining integration, and optimizing workflow. Capable of recording FHD ... Imaging’s new HS Series cameras to be released. The HS Series includes cameras ...
(Date:2/21/2020)... ... 20, 2020 , ... The dietary supplement industry now has ... listed on an ingredient panel is actually in their product. As a ... adoption of CertainT, which is designed to protect the intellectual property (IP) of ...
Breaking Biology Technology:
(Date:2/28/2020)... OMAHA, Neb. (PRWEB) , ... February 28, 2020 , ... ... win the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial ... is a finalist for the Best Clinical Trial Network award. These nominations were the ...
(Date:2/28/2020)... ... 27, 2020 , ... Regen Suppliers is now offering the top FDA Cleared ... products are not only one of the only FDA Cleared options available, there ... increasing exponentially in popularity, as they represent an excellent nonoperative method of reducing wrinkles ...
(Date:2/26/2020)... ... February 25, 2020 , ... Renowned eye surgical practice led by Steven J. ... to offer the FDA-approved, post-surgical, corrective Light Adjustable Lens (LAL) by RxSight™. Since offering ... results. Dell Laser Consultants is also currently involved in the latest LAL FDA study. ...
Breaking Biology News(10 mins):